Researchers elucidate roles of TP63 and SOX2 in squamous cell cancer progression

byNational University of SingaporeCredit: CC0 Public DomainSquamous cell carcinomas (SCCs) are aggressive malignancies arising from the squamous epithelium of various organs, such as the esophag

Updated on: December 18,2023

Researchers elucidate roles of TP63 and SOX2 in squamous cell cancer progression

byNational University of SingaporeCredit: CC0 Public DomainSquamous cell carcinomas (SCCs) are aggressive malignancies arising from the squamous epithelium of various organs, such as the esophag

Updated on:December 18,2023

Cancer mortality continues steady decline, driven by progress against lung cancer

byAmerican Cancer SocietyTrends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population Credit: American Cancer SocietyTh

Updated on: December 22,2023

Cancer mortality continues steady decline, driven by progress against lung cancer

byAmerican Cancer SocietyTrends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population Credit: American Cancer SocietyTh

Updated on:December 22,2023

Gene activation linked to severity of a rare lung cancer

byUniversity of CologneERT expression and telomerase activity in pulmonary carcinoids. Credit:Journal of Clinical Oncology(2024). DOI: 10.1200/JCO.23.02708Pulmonary carcinoids are ra

Updated on: October 24,2024

Gene activation linked to severity of a rare lung cancer

byUniversity of CologneERT expression and telomerase activity in pulmonary carcinoids. Credit:Journal of Clinical Oncology(2024). DOI: 10.1200/JCO.23.02708Pulmonary carcinoids are ra

Updated on:October 24,2024

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez,Baylor College of MedicinenCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/dmice. Three-month-old Pts4d/d&nbsp

Updated on: December 19,2023

Ultrafine particles can change defense against lung cancer

by Graciela Gutierrez,Baylor College of MedicinenCB accelerates NSCLC development and metastasis in mice. (A) Schematic diagram of nCB exposure in Pts4d/dmice. Three-month-old Pts4d/d&nbsp

Updated on:December 19,2023

More breast cancer patients can choose smaller surgery

by Carla K. JohnsonA technician displays images of a mammogram scan on a computer screen at a hospital in Odessa, Texas, on Wednesday, Oct. 20, 2021. A study discussed Friday, Dec. 9, 2022, at the San

Updated on: December 22,2023

More breast cancer patients can choose smaller surgery

by Carla K. JohnsonA technician displays images of a mammogram scan on a computer screen at a hospital in Odessa, Texas, on Wednesday, Oct. 20, 2021. A study discussed Friday, Dec. 9, 2022, at the San

Updated on:December 22,2023

Ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas

byUniversity of Texas M. D. Anderson Cancer Center3D rendering of a B cell. Credit: Blausen.com staff (2014). "Medical gallery of Blausen Medical 2014". WikiJournal of Medicine 1 (2).

Updated on: December 19,2023

Ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas

byUniversity of Texas M. D. Anderson Cancer Center3D rendering of a B cell. Credit: Blausen.com staff (2014). "Medical gallery of Blausen Medical 2014". WikiJournal of Medicine 1 (2).

Updated on:December 19,2023

Breakaway breast cancer cells can travel to the brain: Scientists plot path in quest to block entry

by Delthia Ricks , Medical XpressIn vitro characterization of in vivo / ex vivo-derived 4T1 metastatic cell lines. (A) Schematic representation of the procedure used to generate the 4T1-BM2 metastatic

Updated on: December 22,2023

Breakaway breast cancer cells can travel to the brain: Scientists plot path in quest to block entry

by Delthia Ricks , Medical XpressIn vitro characterization of in vivo / ex vivo-derived 4T1 metastatic cell lines. (A) Schematic representation of the procedure used to generate the 4T1-BM2 metastatic

Updated on:December 22,2023

Unveiling uremic toxins linked to itching in hemodialysis patients

FEBRUARY 19, 2024byNiigata UniversitySeverity and distribution of itching in hemodialysis patients. Credit: Niigata UniversityHemodialysis patients commonly experience itching on a daily basis,

Updated on: March 15,2024

Unveiling uremic toxins linked to itching in hemodialysis patients

FEBRUARY 19, 2024byNiigata UniversitySeverity and distribution of itching in hemodialysis patients. Credit: Niigata UniversityHemodialysis patients commonly experience itching on a daily basis,

Updated on:March 15,2024

Pinpointing the prevalence of mismatch repair (MMR)-deficient rectal adenocarcinomas

byBrigham and Women's HospitalCredit: Pixabay/CC0 Public DomainA widely-circulated clinical trial published earlier this year in theNew England Journal of Medicine (NEJM)describe

Updated on: December 26,2023

Pinpointing the prevalence of mismatch repair (MMR)-deficient rectal adenocarcinomas

byBrigham and Women's HospitalCredit: Pixabay/CC0 Public DomainA widely-circulated clinical trial published earlier this year in theNew England Journal of Medicine (NEJM)describe

Updated on:December 26,2023

Researchers find the key to genome-modifying drugs' sensitivity in malignant blood diseases

by Josep Carreras Leukaemia Research InstituteImpact of azacitidine on global DNA methylation patterns and definition of EPIAZA signature in patients with MDS. (A) Study design and workflow. (B,

Updated on: March 20,2024

Researchers find the key to genome-modifying drugs' sensitivity in malignant blood diseases

by Josep Carreras Leukaemia Research InstituteImpact of azacitidine on global DNA methylation patterns and definition of EPIAZA signature in patients with MDS. (A) Study design and workflow. (B,

Updated on:March 20,2024

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

byScience China PressThe CDK4/6 inhibitors-resistant breast cancer cells expressed more Cyclin D1 and CDK4 proteins than the parental cells (Upper left). PI3K pathway was hyper-activated in the

Updated on: December 23,2023

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

byScience China PressThe CDK4/6 inhibitors-resistant breast cancer cells expressed more Cyclin D1 and CDK4 proteins than the parental cells (Upper left). PI3K pathway was hyper-activated in the

Updated on:December 23,2023

Why breast cancer survivors don't take their medication, and what can be done about it

by Lisa Marshall,University of Colorado at BoulderCredit: Unsplash/CC0 Public DomainFor roughly 80% of breast cancer survivors, treatment doesn't end with surgery, radiation and chemotherapy

Updated on: January 08,2024

Why breast cancer survivors don't take their medication, and what can be done about it

by Lisa Marshall,University of Colorado at BoulderCredit: Unsplash/CC0 Public DomainFor roughly 80% of breast cancer survivors, treatment doesn't end with surgery, radiation and chemotherapy

Updated on:January 08,2024